血管化瘤芯片模型作为研究瘤-微环境-药物相互作用的平台
Hyelim Kim1,2, Seung-Woo Cho1,3, Hong Nam Kim2,4,5,6
1Department of Biotechnology, Yonsei University, Seoul, Republic of Korea.
Macromolecular bioscience
|July 22, 2025
概括
血管化的瘤芯片系统在现实瘤微环境 (TME) 中提供药物输送系统 (DDS) 的高级3D评估. 这些微流体平台通过提高临床前到临床翻译性来改善癌症药物开发.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 药物输送系统 药物输送系统
背景情况:
- 传统的癌症模型无法复制复杂的人类瘤微环境 (TME).
- 现有的模型缺乏在病理模拟条件下评估药物输送系统 (DDS) 所需的复杂性.
- 跨物种的变异性,简化的结构和静态 perfusion 限制了当前临床前模型的可翻译性.
研究的目的:
- 审查血管化瘤芯片技术的最新进展,以评估DDS性能.
- 突出这些系统在评估药物运输动力学和在动态的TME中治疗疗效方面的能力.
- 讨论这些平台在精确瘤学和整合性器官级建模方面的潜力.
主要方法:
- perfusable 血管系统与微流体环境中的瘤-流体动态的整合.
- 开发动态3D模型,模拟人类瘤微环境 (TME).
- 利用微流体系统来评估药物输送系统 (DDS) 的性能.
主要成果:
- 血管化的瘤芯片系统能够动态3D评估药物运输和疗效.
- 这些先进的模型显著提高了癌症治疗的临床前临床翻译性.
- 在维持长期血管稳定性和在生理流动下多组织融合方面,仍然存在挑战.
结论:
- 血管化的瘤芯片平台代表了评估癌症药物输送系统的重大飞跃.
- 这些技术在精密瘤学和下一代癌症研究方面具有变革性的潜力.
- 需要进一步开发以应对血管稳定性和多组织集成方面的挑战,以进行全面的建模.
相关概念视频
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...